Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis

AZD-5847 is a new oxazolidinone derivative under development for the treatment of tuberculosis (TB). Here we describe the population pharmacokinetics (PK) of AZD-5847 in patients with tuberculosis based on a recently completed phase II study. The study included 60 patients with drug-susceptible TB....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Alsultan, Abdullah, Furin, Jennifer J., Du Bois, Jeannine, van Brakel, Elana, Chheng, Phalkun, Venter, Amour, Thiel, Bonnie, Debanne, Sara A., Boom, W. Henry, Diacon, Andreas H., Johnson, John L., Peloquin, Charles A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5610519/
https://ncbi.nlm.nih.gov/pubmed/28739794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01066-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados